Kaye Mark bought ELV
October 2, 2026 · Form 4 insider transaction
Kaye Mark bought 2,627 shares of Elevance Health, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,627
Price
$0.00
Total value
N/A
InsiderKaye Mark
Role—
CompanyElevance Health, Inc. (ELV)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateOctober 2, 2026
Filing dateOctober 6, 2026
Shares owned after30,503
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents performance based restricted share units. Restrictions lapsed on 10/2/2026.